Purgason v. Secretary of Health and Human Services

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 12-465V Filed: April 4, 2016 * * * * * * * * * * * * * * * * UNPUBLISHED TRACY PURGASON, * * Special Master Gowen Petitioner, * * Joint Stipulation on Damages; v. * Measles-Mumps-Rubella (“MMR”); * Tetanus-Diphtheria-Acellular SECRETARY OF HEALTH * Pertussis (“Tdap”); AND HUMAN SERVICES, * Chronic Arthritis; Wegener’s * Granulomatosis.

Respondent. * * * * * * * * * * * * * * * * * * Mark T. Sadaka, Mark T. Sadaka, LLC, Englewood, NJ, for petitioner.

Lisa A. Watts, United States Department of Justice, Washington, DC, for respondent.

DECISION ON JOINT STIPULATION1 On July 25, 2012, Tracy Purgason (“petitioner”) filed a petition pursuant to the National Vaccine Injury Compensation Program.2 42 U.S.C. §§ 300aa-1 to -34 (2012). Petitioner alleged that as a result of receiving a measles-mumps-rubella (“MMR”) vaccine and a tetanus-diphtheria- acellular pertussis (“Tdap”) vaccine on June 27, 2011, she developed rubella-induced chronic arthritis and Wegener’s granulomatosis. Stipulation for Award at ¶ 2, 4, filed Mar. 30, 2016.

Further, petitioner alleged that she experienced residual effects of her injury for more than six

Because this decision contains a reasoned explanation for the undersigned’s action in this case, the undersigned intends to post this ruling on the website of the United States Court of Federal Claims, in accordance with the E-Government Act of 2002, 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). As provided by Vaccine Rule 18(b), each party has 14 days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b).

The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, U.S.C. §§ 300aa-1 to -34 (2012) (Vaccine Act or the Act). All citations in this decision to individual sections of the Vaccine Act are to 42 U.S.C.A. § 300aa.

months. Id. at ¶ 4.

On March 30, 2016, the parties filed a stipulation in which they state that a decision should be entered awarding compensation. Respondent denies that the MMR and Tdap vaccinations caused petitioner’s alleged chronic arthritis and Wegener’s granulomatosis, or any other injury; and further denies that petitioner’s current disabilities are sequelae of a vaccine-related injury. Id. at ¶ 6. Nevertheless, the parties agree to the joint stipulation, attached hereto as Appendix A. The undersigned finds the stipulation reasonable and adopts it as the decision of the Court in awarding damages, on the terms set forth therein.

The parties stipulate that petitioner shall receive the following compensation: A lump sum of $225,000.00, in the form of a check payable to petitioner, Tracy Purgason. This amount represents compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a).

Id. at ¶ 8.

The undersigned approves the requested amount for petitioner’s compensation.

Accordingly, an award should be made consistent with the stipulation.

The clerk of the court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ stipulation.3 IT IS SO ORDERED.

s/ Thomas L. Gowen Thomas L. Gowen Special Master

Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of notice renouncing the right to seek review.